New COVID-19 case in Whale Cove brings Nunavut’s active cases to nine
6,000 doses of Moderna vaccine en route to Nunavut in early January, health officials say
Nunavut has one new active case of COVID-19 Dec. 28: the second case in Whale Cove since the virus re-emerged in the Kivalliq community.
The Government of Nunavut announced a new case of COVID-19 in Whale Cove last week, which was the first new active case announced since a small outbreak of 21 cases — all now recovered — were identified in the community earlier this month.
As of Dec. 28, there are now two active cases of COVID-19 in Whale Cove and seven active cases in Arviat, the GN noted in its updated statistics Dec. 28.
As of this week, 2,219 Nunavummiut have been tested for the virus. Of the 266 who have tested positive for COVID-19 across the territory, 256 have now recovered.
Nunavut is set to receive its first batch of the newly-approved Moderna vaccine in early January, health officials say — an initial shipment of 6,000 doses.
The GN estimates the territory will have received enough of Moderna’s vaccine to inoculate 75 per cent of adults across the territory by the end of March 2021.
The GN urges anybody who thinks they have been exposed to COVID-19 to call 1-888-975-8601, or notify their community health centre, and immediately start a 14-day isolation.